SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Fundamental Value Investing -- Ignore unavailable to you. Want to Upgrade?


To: bruwin who wrote (1188)5/14/2010 7:44:47 AM
From: The Ox  Read Replies (1) | Respond to of 4719
 
I had the same thoughts, bruwin, a concern that they are spending a lot more money and getting less revenue in return. This maybe temporary, as it often takes time to reap the rewards of the spending increases. Share count has increased 6% yoy. Even though net income/revs has stayed consistent, dilution chips away slightly at earnings on a per share basis.

Expanding into new markets costs and that maybe where the shorts are expecting further deterioration to show up in the bottom line numbers, in near to intermediate term?



To: bruwin who wrote (1188)8/9/2010 2:53:56 PM
From: bruwin2 Recommendations  Read Replies (1) | Respond to of 4719
 
EBIX - Latest Q2 Results.

In their latest set of results, EBIX has shown an increase in virtually every positive item.
The percentage Quarterly Revenue increase is not as it was several quarters ago, but it has nearly doubled in the last 3 months.

EBITDA Margin and Bottom Line Margin are both well up, and sit at 48.1% and 43.5% respectively.

Pretax Return on Cap.Employed is also up from 19.8% to 21.5%.

Basic EPS is also up by 11% to 40c.

The share price opened at $17.16c today, and is currently trading at over $18.60c, which is the highest since 4 Nov. 2009.

It will be interesting to see how the Short Sellers of EBIX react, .... going forward.

Don't know about others, but I'll certainly be hanging onto my company stock.

EBIX Quarterlies :-       09/03 09/06 09/09 09/10 10/03  10/06 

Revenue 20.7 22.4 23.3 31.3 31.6 32.2
CoS 4.1 4.5 4.5 8.0 7.0 7.4
SG&A+R&D 7.5 7.8 8.1 10.0 10.4 9.3
EBITDA 9.1 10.1 10.7 13.3 14.2 15.5
Interest Expense 0.3 0.3 0.2 0.3 0.3 0.3
Pretax Income(TTM) 31.3 33.9 35.8 39.8 44.3 49.4
Net Income 8.3 9.0 9.4 12.1 12.4 14.0

Capital Employed 95.7 120.7 124.2 187.1 223.4 230.1

Revenue Increase 8.2% 4.0% 34.3% 1.0% 1.9%
CoS/Revenue 19.8% 20.1% 19.3% 25.6% 22.2% 23.0%
SG&A+R&D/Revenue 36.2% 34.8% 34.8% 31.9% 32.9% 28.9%
EBITDA/Revenue 44.0% 45.1% 45.9% 42.5% 44.9% 48.1%
Int.Expense/EBITDA 3.3% 3.0% 1.9% 2.3% 2.1% 1.6%
Pretax Inc./Cap.Employed 32.7% 28.1% 28.8% 21.3% 19.8% 21.5%
Net Inc./Revenue 40.1% 40.2% 40.3% 38.7% 39.2% 43.5%

Basic EPS (Cents) 28 29 30 36 36 40